Multiple criteria decision analyisis for health technology assessment: scientific substantiation of criteria selection in Ukraine
Journal Title: Фармацевтичний журнал - Year 2017, Vol 5, Issue 5
Abstract
Multiple-criteria decision analysis (MCDA) is a framework where multiple criteria are being considered in a well-structured manner during the decision-making process. This methodology is becoming increasingly popular for aiding and supporting health-care decision making. Defining the criteria is a critical stage in the process as it forms the foundation of MCDA. Our aim was to review information sources on the application of MCDA in practice in the world and to analyze the criteria included in the MCDA models. Research objects were MCDA reports and models from PubMed database. Research methods were system and content analyzes, data synthesis, generalization, extrapolation, statistical. We reviewed scientific publications and official documents of existing or proposed MCDA models. We identified the criteria and assigned them into nine groups: Economics, Disease description, Intervention description, Health gain, Feasibility, Prevalence, Evidence quality, Social and ethical factors and Other criteria. We looked at MCDAs which are aimed to be used for Reimbursement or Investment Decisions (86%) and for Authorization Decisions (14%). Of the reviewed 25 MCDA models aimed to support reimbursement decisions only 1 lacks cost-related criteria, while 7 scoring systems lack social and ethical factors and 12 MCDAs don’t mention epidemiology or classification of target groups directly. We found that none of the reviewed MCDAs used for authorization decisions mentioned socioeconomic criteria. There is no direct connection between the number of criteria included in MCDA models intended to support reimbursement decisions and the GDP per capita figures of countries. It can be seen that the selection of criteria has no standardized approach yet and most of the existing or proposed MCDA models were conducted to be relevant for decision-makers in the particular decision problems. The MCDAs supporting reimbursement decisions considered more criteria and the majority of them included economics and societal factors while most MCDAs intended to support authorization decisions only focused on the potential health benefits and outcomes. The most MCDA models included in our research were built in high-income countries.
Authors and Affiliations
O. B. Piniazhko, Olha Zaliska
Pharmaco-technological researches for development of sachet composition
In the article it is presented data on the relevance of drugs from the group of analgesics-antipyretics in the form of fast dissolving solid dosage forms and excipients for its manufacture are described. The advantages o...
Research of plant mixtures of raspberries (Rubus idaeus L.) leaves
One of the most actual problem of modern pharmaceutical chemistry is standardization of herbal raw materials and improvement of methods of quality control multicomponent herbal medicines. A promising way to improve stand...
Identification and determination quantitative composition of flavonoids grass common toadflax (Linaria vulgaris Mill.)
Providing each person and affordable medicine sinsufficient quantities–one of the main tasks of any state. One source of creation of new effective drugs is a medicinal plant material of appropriate quality and proven pha...
Decametoxin and chlorhexidin at the domestic pharmaceutical market
Realization of marketing researches of home pharmaceutical market in the presence of drugs farmakotherapeutic group always is actual, as he allows to find out gap-fillingness of market of medications. The aim of this ana...
The modern state and development trends of the normative legal adjusting in the sector of the quality assurance of medicinal products
The one of important factors of creation and effective functioning of the quality assurance system of medicinal products is the normative adjusting of the questions related to her through normative legal acts, harmonized...